Newsletter of MEDICA | View in browser | Deutsch | Print
Header of MEDICA Newsletter

Testing framework for secure AI applications

Dear Sir or Madam,

How can nations ensure the quality of training data for medical AI applications? In our interview, Dr. Daniel Schwabe explains how Germany's TEF-Health project helps companies to ensure the quality of AI training data. Why is this validation crucial for the safety of medical AI products?

Enjoy reading!

Tim Plato
Editorial team MEDICA-tradefair.com

Table of Contents

Interview: AI test framework for data quality
Newsletter Service

AI: New testing framework to ensure the quality of training data

Interview – DIGITAL HEALTH

Image: Tablet lying on a table, a person in a doctor's coat reaches for the tablet with both hands
How can the quality of training data for AI applications in medical technology be ensured? Dr. Daniel Schwabe from Germany's national metrology institute (PTB) explains in an interview how the new testing framework of the TEF Health project can help. Find out how companies can benefit from these tools!
Click here for the interview
How a new testing framework ensures the quality of medical AI data
Image: Banner with the text: Discover the world of DIGITAL HEALTH here; Copyright: Messe Düsseldorf
To top

Sweat-powered finger wrap enables continuous health monitoring

News

DIGITAL HEALTH

Engineers at the University of California San Diego have developed a sweat-powered finger wrap that monitors vital health biomarkers such as glucose, lactate, vitamin C, and levodopa. This wearable device utilizes sweat from the wearer’s fingertip for both power and health monitoring, making it a convenient and non-invasive tool for personalized health tracking.
read more
To top

Ultrasound promotes blood vessel growth in damaged tissue

News

MED TECH & DEVICES

A team of researchers at the University of Rochester has developed a new approach using ultrasound technology to promote the growth of blood vessels in damaged tissue. The method could have significant applications in reconstructive and plastic surgeries, as well as wound healing.
read more
To top

Superhydrophobic device to model tumor progression

News

LAB & DIAGNOSTICS

Rice University bioengineers have harnessed the lotus leaf's unique properties to create a cutting-edge platform for culturing cancer cell clusters. This system offers a new approach to studying tumor progression and metastasis, providing essential insights into cancer biology and treatment.
read more
To top

Company News, MED TECH & DEVICES

Helping medical device start-ups succeed: Your journey, our expertise.

D.med Software S.L.U.

read more
As a medical device startup, you're driven by innovation, but the journey to turn your idea into a successful product can feel overwhelming. At D.med Technologies, we understand the unique...
To top

MED TECH & DEVICES, Company News

When Virtual Reality Meets Artificial Intelligence: How Freudenberg Medical is Transforming Training and Factory Layout Planning

Freudenberg Medical Europe GmbH

read more
Freudenberg Medical is redefining manufacturing by combining Virtual Reality (VR) and Artificial Intelligence (AI) to enhance training, streamline production, and drive efficiency across global sites.
To top

Newsletter Service

You like our newsletter? Then please recommend us: Forward this newsletter or the link www.MEDICA.de/news_login_2 to your friends and colleagues.

If you have difficulties with your order, please write an e-mail to medica-redaktion@messe-duesseldorf.de.

To top
Legal disclaimer

Messe Düsseldorf GmbH
Messeplatz, Stockumer Kirchstr. 61
40474 Düsseldorf, Germany

Phone: +49 211 4560-01
Fax: +49 211 4560-668
www.messe-duesseldorf.de
info@messe-duesseldorf.de

County Court Düsseldorf HRB 63

Board of Managing Directors: Wolfram N. Diener (Chairman), Marius Berlemann, Bernhard J. Stempfle

Chairman of Supervisory Board: Mayor Dr. Stephan Keller

Messe Düsseldorf GmbH processes personal data relating to you. You can find more information - also on your rights - in the privacy policy of Messe Düsseldorf GmbH available at www.messe-duesseldorf.de/privacy. In principle, i.e. subject to legal restrictions, you may at any time object to the processing of your personal data either on the aforementioned website, via e-mail to privacy@messe-duesseldorf.de or via postal mail to Messe Düsseldorf GmbH, G2-RV, PF 101006, 40001 Düsseldorf, Germany.

Facebook LinkedIn YouTube

Should you no longer wish to receive our newsletter, please click here.